IL37 and amyloidosis: There is also evidence that IL-23 has a role in Alzheimer ́s disease, as amyloidosis-prone APPPS1 mice lacking IL-23 and IL-12 have a decreased in amyloid-β plaque burden, and the administration of p40 neutralizing antibodies reduced the pathology [227].